Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daneil J DeAngelo, MD, PhD.
Dana Farber Cancr Institute
Principal Investigator - Swaminathan Padmanabhan, MD
Cancer Therapy Research Center at UTHSCSA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Brigham & Women'S Hospital
Boston, Massachusetts, United States
Recruiting - Dana Farber Cancer Institute
Boston, Massachusetts, United States
Adriana Penicaud, PADaneil J DeAngelo, MD, PhD.Eyal Attar, MDGregory Abel, MD, MPHIlene Galinsky, APRNKaren Kuhn Ballen, MDL. Andres Sirulnik, MDMartha Wadleigh, MDPhilip Amrein, MDRichard Stone, MDSusan L Buchanan, PARecruiting - Cancer Therapy Reasearch Center at Uthsca
San Antonio, Texas, United States
Alain Mita, MDMonica Mita, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2008
- Primary completion
- 31 Dec 2010
- Completion
- 31 Dec 2010
- Last update posted
- 9 Jan 2009
- Registered enrollment
- 44
- Registry id
- NCT00709215
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.